Akanda (AKAN) Accounts Payables (2020 - 2025)
Akanda's (AKAN) quarterly Accounts Payables came in at $3.3 million in Q4 2025, up 10.95% year-on-year from $3.0 million in Q4 2024, and up 50.08% quarter-over-quarter from $2.2 million in Q2 2025.
Akanda (AKAN) Accounts Payables (2020 - 2025) Analysis & Trends
Akanda's Accounts Payables history runs 6 years deep, the most recent figure standing at $3.3 million for Q4 2025.
- On a quarterly basis, Accounts Payables rose 10.95% year-over-year to $3.3 million in Q4 2025; TTM through Dec 2025 was $3.3 million, a 10.95% increase from a year earlier, with the FY2025 full-year figure at $3.3 million, up 10.95% from the prior year.
- Accounts Payables grew to $3.3 million in Q4 2025 per AKAN's latest filing, from $2.2 million in the prior quarter.
- Across five years, Accounts Payables topped out at $8.5 million in Q2 2023 and bottomed at $680328.0 in Q4 2021.
- The 5-year median for Accounts Payables is $3.8 million (2024), against an average of $4.3 million.
- Across the five-year window, Accounts Payables surged 949.47% in 2022 and slumped 55.55% in 2024, its largest moves.
- Year by year, Accounts Payables stood at $680328.0 in 2021, then jumped by 949.47% to $7.1 million in 2022, then dropped by 15.76% to $6.0 million in 2023, then plunged by 50.41% to $3.0 million in 2024, then rose by 10.95% to $3.3 million in 2025.
- Per Business Quant, the three latest AKAN Accounts Payables figures stand at $3.3 million (Q4 2025), $2.2 million (Q2 2025), and $3.0 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 507.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 498.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 1.67 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 372.00 Mn |
| 10 | Akanda | 556,353.85 | 556,353.85 | - | 3.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.31 Mn |
| Jun 30, 2025 | 2.20 Mn |
| Dec 31, 2024 | 2.98 Mn |
| Jun 30, 2024 | 3.76 Mn |
| Dec 31, 2023 | 6.01 Mn |
| Jun 30, 2023 | 8.46 Mn |
| Dec 31, 2022 | 7.14 Mn |
| Jun 30, 2022 | 4.49 Mn |
| Dec 31, 2021 | 680,328.00 |
| Dec 31, 2020 | 183,895.00 |